Newsletter | September 15, 2023

09.15.23 -- Balanced Sourcing Of Custom Media/Buffer Formulations: The Case For Outsourcing


Interested in bringing your monoclonal antibody from transfection to GMP drug substance in 9 months?

Join a panel discussion to explore our Accelerated mAb Development Program. Meet the experts who have developed our phase-appropriate and cost-effective program, which is scalable and integrates strategies for risk mitigation. Watch now.


Balanced Sourcing Of Custom Media/Buffer Formulations: The Case For Outsourcing

Nothing is risk-free. Now more than ever, all sourcing options have pros and cons that we need to assess to find the best fit. In this first article of a two-part series, we share three compelling reasons to consider outsourcing, along with key considerations for each.


Embracing LC-MS Analytical Techniques Into Regulated Laboratories

We address the additional compliance challenge in biopharma of the requirement of complex analytical instruments that are not traditionally used in highly regulated labs.

Delivering Genetic Editing Therapies To Market

Manufacturers with proven expertise in areas such as viral vector production and analytics are needed now more than ever to get breakthrough, deliverable gene editing therapies to patients.

Growing With A Flexible, Collaborative CDMO

Choosing a CDMO that is agile, innovative, and exhibits a willingness to invest in new equipment, infrastructure, and services will allow the innovator company and the CDMO to grow together.

Four Special Fill/Finish Considerations For Vaccine Production

Examine considerations regarding the handling and process for fill/finish to ensure the stability and purity of your vaccine as well as to limit unnecessary waste and cost.

Alternatives To In Vivo Assays For Biosafety Testing Of Biologics

Even as alternative methods such as PCR and NGS have emerged, in vivo tests have stubbornly remained a central part of testing. Examine current in vivo methods and modern alternatives.

Faster R&D Of Pharma Production Lines

This use case demonstrates a solution that empowers users by connecting to all relevant data sources to visually represent batches and perform analytics with process data.

The Future Of Plug-And-Play Large-Scale Viral Vector Manufacturing

Explore AAV-based gene therapy production to manage adherent and suspension processes, and new approaches for creating large-scale AAV production that can meet any product specification.

The Criticality Of Cell Culture Media Analysis For Cell And Gene Therapies

This short webinar explores what is already known about cell culture media analysis, reviews at-line methods for cell culture media analysis, and shares recent data from two case studies.

Strategies, Emerging Technologies For mAb Capture

Explore opportunities with the introduction of high-capacity protein A resins, how and when multicolumn chromatography is beneficial, and how emerging technologies can address bottlenecks.


Key Elements To Drug Product Process Characterization For Liquid And Lyophilized DP To Support A BLA Submission

Discover strategies proven to significantly improve timelines and success to market, as industry experts guide you through important initial steps to consider and implement during the process design phase. Understand Lonza’s approach to process characterization and explore recent learnings pertaining to adapting to new Annex I requirements for sterile manufacturing. Click here to learn more.


Changing The Healthcare Landscape

mRNA/LNP Development And Manufacturing Services

Advancing Vaccines From Preclinical Development To Commercial Supply

Gibco Bacto CD Supreme Fermentation Production Medium (FPM)

How To Close An Ear Clamp

Quality, Compliance, And Regulatory Services For Life Sciences

NanoAssemblr Ignite: Power To Advance


Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.

Connect With Bioprocess Online: